<video id="l7dhl"></video>

      <del id="l7dhl"></del>
      <output id="l7dhl"><dfn id="l7dhl"><span id="l7dhl"></span></dfn></output>
      <address id="l7dhl"></address>

      <p id="l7dhl"><dfn id="l7dhl"></dfn></p>
      <ruby id="l7dhl"></ruby>
        <del id="l7dhl"></del>
        <address id="l7dhl"></address>


        International Market

        Hansoh actively implements the internationalization strategy and has been committed itself to human being’s health with its professional expertise, through sales of internationally certified APIs and finished-dose pharmaceutical products to  the U.S. and other countries, and  international multi-center clinical trials for innovative drugs.   

        Market Internationalization 

        Multiple finished-dose pharmaceutical products and APIs are sold to the global market. 

        R&D Internationalization 

        Global multi-center clinical trials are under way simultaneously in the U.S. and China for HS-10296, a Category 1.1 innovative oncology drug, amid efforts for global expansion of innovative drugs.